Amicus Therapeutics, Inc. 8-K Report: Key Updates as of January 12, 2025

Here’s a summary of the key information extracted from the provided financial report section:

1. Entity Information:

• Name: Amicus Therapeutics, Inc.
• State of Incorporation: Delaware (DE)
• CIK Number: 0001178879
• IRS Employer Identification Number: 71-0869350
• Address: 47 Hulfish Street, Princeton, NJ 08542
• Phone Number: 609-662-2000

2. Filing Information:

• Filing Type: 8-K
• Filing Date: January 12, 2025
• SEC File Number: 001-33497

3. Common Stock Details:

• Par Value: $0.01
• Ticker Symbol: FOLD
• Exchange: NASDAQ

4. Financial Reporting Context:

• Report Date: January 12, 2025 (as of date)
• Currency: USD (US Dollars)
• Measurement Units:
• • USD (for monetary values)
  • Shares (for stock quantities)
  • USD per Share (for pricing)

Insights:

• The report indicates a specific event or financial update related to Amicus Therapeutics as filed on an 8-K, which is typically used to report major events that shareholders should know about.
• The choice of a common stock with a low par value of $0.01 suggests a potential for higher share issuance flexibility.
• The report is structured in compliance with XBRL (eXtensible Business Reporting Language), indicating a commitment to transparent and standardized financial reporting.

This information is crucial for stakeholders looking to understand the company’s operational status and recent developments as of the specified filing date.